Replimune Skin Cancer Therapy Fails Midstage Study : compare

Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove or reduce cancerous lesions in a midstage study.

Related Keywords

Massachusetts , United States , Bengaluru , Karnataka , India , Evan Seigerman , Arun Koyyur , Puyaan Singh , Sriraj Kalluvila , Reuters , Replimune Group , Mariam Sunny , Skin Cancer , Alignant Skin Neoplasm , Cancer , Alignant Neoplasia , Arcinoma , Squamous Carcinoma , Immunotherapy ,